• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Mass screening for prostate cancer in Japan].

作者信息

Akimoto S, Ichikawa T, Shimazaki J

机构信息

Department of Urology, School of Medicine, Chiba University.

出版信息

Nihon Rinsho. 1996 May;54(5):1447-51.

PMID:8965383
Abstract

Since 1975 mass screening for prostate cancer has been performed in Japan. The Prostate Research Foundation has analysed the data every year that collected from all institutes performing a mass screening. Up to 1993, 67, 225 subjects were examined. The detection rate of prostate cancer was 0.69%. Approximately half of the cancer were stage B, and the subjects who have metastatic stage were only 20% and the pattern of stage seemed to be different from that of patients who visited hospitals. In Chiba prefecture the subjects lived in a district of south Boso peninsula received a mass screening for prostate cancer with total of 1,964 men from 1985, and 17 cancers were diagnosed (0.87%). The distribution of prostate-specific antigen (PSA) assayed with Tandem-R kit was examined using the stocked sera (n = 976) of the screening for prostate cancer in Chiba prefecture. The percentage of 0.05-4.0 ng/ml, 4.1-9.9 ng/ml, over than 10.0 ng/ml of the PSA, were 89.6%, 7.0%, 3.4%, respectively. This distribution is approximately as same as the previous reports by the United States and Canada.

摘要

相似文献

1
[Mass screening for prostate cancer in Japan].
Nihon Rinsho. 1996 May;54(5):1447-51.
2
Prostate-specific antigen kinetics in screen-detected prostate cancer in Japan.日本筛查发现的前列腺癌中前列腺特异性抗原动力学
Urology. 2008 Nov;72(5):1111-5. doi: 10.1016/j.urology.2007.12.090. Epub 2008 Mar 17.
3
[Prostate cancer screening using prostate specific antigen (PSA) in Tokatsu Hospital--examination of lost-to-followup cases].
Hinyokika Kiyo. 1998 Mar;44(3):155-8.
4
Prostate carcinoma detection and increased prostate-specific antigen levels after 4 years in Dutch and Japanese males who had no evidence of disease at initial screening.在初次筛查时无疾病证据的荷兰和日本男性中,4年后前列腺癌的检测及前列腺特异性抗原水平升高。
Cancer. 2005 Jan 15;103(2):242-50. doi: 10.1002/cncr.20739.
5
Ten year trend in prostate cancer screening with high prostate-specific antigen exposure rate in Japan.日本前列腺特异性抗原高暴露率下前列腺癌筛查的十年趋势
Int J Urol. 2008 Feb;15(2):156-60; discussion 161. doi: 10.1111/j.1442-2042.2007.01957.x.
6
[Diagnosis of localized prostate cancer: screening and preoperative staging].
Urologe A. 1991 Nov;30(6):378-86.
7
Mass screening of prostate cancer and its impact on inhabitants in Akita Prefecture, Japan.日本秋田县前列腺癌的大规模筛查及其对居民的影响。
Aktuelle Urol. 2010 Jan;41 Suppl 1:S53-6. doi: 10.1055/s-0029-1224653. Epub 2010 Jan 21.
8
[Results and participation factors to the European Randomized study of Screening for Prostate Cancer (ERSPC) with Prostate Specific Antigen: French departments of Tarn and Hérault].[欧洲前列腺癌筛查随机研究(ERSPC)中前列腺特异性抗原的结果及参与因素:塔恩省和埃罗省的法国部门]
Prog Urol. 2009 Jul;19(7):487-98. doi: 10.1016/j.purol.2009.03.001. Epub 2009 Apr 28.
9
[A mass screening of the prostatic diseases and serum prostate specific antigen].[前列腺疾病与血清前列腺特异性抗原的大规模筛查]
Hinyokika Kiyo. 1991 Aug;37(8):887-90.
10
Prostate-specific antigen levels in the United States: implications of various definitions for abnormal.美国前列腺特异性抗原水平:异常的各种定义的影响
J Natl Cancer Inst. 2005 Aug 3;97(15):1132-7. doi: 10.1093/jnci/dji205.